Skip to main content
SpringerLink
Log in

MicroRNA Profiling and Its Application in Drug Discovery in Pancreatic Cancer

  • Chapter
  • First Online:
Drug Discovery in Pancreatic Cancer

  • 694 Accesses

Abstract

MicroRNAs (miRNAs) are single-stranded small RNA molecules of 21–23 nucleotides in length, involved in regulation of gene expression. An emerging number of studies show that miRNAs play a vital role in important signaling pathways in human oncogenesis. miRNAs can be utilized as potential biomarkers for cancer diagnosis and also as candidates in cancer treatment drug development. Pancreatic cancer is a lethal disease and is the fourth leading cause of cancer-related deaths in the United States. One key factor that can make an impact is earlier diagnosis of the disease, when surgery could offer patients a chance of cure. Use of miRNAs for early detection and drug development offers a unique opportunity. Identification and assessment of miRNA functionality that are differentially expressed in pancreatic cancer originates from methods for miRNA profiling such as miRNA microarray, in situ hybridization, and various computational algorithms applied for data analysis. This chapter discusses the various profiling methods applied to the identification of differentially expressed miRNAs in pancreatic cancer, which can applied towards drug development for pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bai G, Ambalavanar R, Wei D et al (2007) Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain 3:15

    Article  PubMed  Google Scholar 

  • Bandres E, Agirre X, Ramirez N et al (2007) MicroRNAs as cancer players: potential clinical and biological effects. DNA Cell Biol 26:273–282

    Article  CAS  PubMed  Google Scholar 

  • Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297

    Article  CAS  PubMed  Google Scholar 

  • Bloomston M, Frankel WL, Petrocca F et al (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297:1901–1908

    Article  CAS  PubMed  Google Scholar 

  • Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

    CAS  PubMed  Google Scholar 

  • Calin GA, Liu CG, Sevignani C et al (2004a) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101:11755–11760

    Article  CAS  Google Scholar 

  • Calin GA, Sevignani C, Dumitru CD et al (2004b) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101:2999–3004

    Article  CAS  Google Scholar 

  • Cho WC (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60

    Article  PubMed  Google Scholar 

  • Cummins JM, He Y, Leary RJ et al (2006) The colorectal microRNAome. Proc Natl Acad Sci U S A 103:3687–3692

    Article  CAS  PubMed  Google Scholar 

  • Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer. Oncogene 25:6170–6175

    Article  CAS  PubMed  Google Scholar 

  • Dillhoff M, Liu J, Frankel W et al (2008) MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 12:2171–2176

    Article  PubMed  Google Scholar 

  • Eis PS, Tam W, Sun L et al (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102:3627–3632

    Article  CAS  PubMed  Google Scholar 

  • Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259–269

    Article  CAS  PubMed  Google Scholar 

  • Fabbri M, Croce CM, Calin GA (2008) MicroRNAs. Cancer J 14:1–6

    Article  CAS  PubMed  Google Scholar 

  • Gallegos Ruiz MI, Floor K, Rijmen F et al (2007) EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens. Cell Oncol 29:257–264

    Google Scholar 

  • Gold DV, Modrak DE, Ying Z et al (2006) New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol 24:252–258

    Article  CAS  PubMed  Google Scholar 

  • Grote T, Logsdon CD (2007) Progress on molecular markers of pancreatic cancer. Curr Opin Gastroenterol 23:508–514

    Article  CAS  PubMed  Google Scholar 

  • Johnson SM, Grosshans H, Shingara J et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120:635–647

    Article  CAS  PubMed  Google Scholar 

  • Kalikaki A, Koutsopoulos A, Trypaki M et al (2008) Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC. Br J Cancer 99:923–929

    Article  CAS  PubMed  Google Scholar 

  • Krichevsky AM, King KS, Donahue CP et al (2003) A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9:1274–1281

    Article  CAS  PubMed  Google Scholar 

  • Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854

    Article  CAS  PubMed  Google Scholar 

  • Lee EJ, Gusev Y, Jiang J et al (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120:1046–1054

    Article  CAS  PubMed  Google Scholar 

  • Li D, Xie K, Wolff R et al (2004) Pancreatic cancer. Lancet 363:1049–1057

    Article  CAS  PubMed  Google Scholar 

  • Linardou H, Dahabreh IJ, Kanaloupiti D et al (2008) Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol 9(10):962–972

    Article  CAS  PubMed  Google Scholar 

  • Liu F, Jiang B, Gong SJ et al (2007) [Mutational analysis of EGFR and K-RAS in Chinese patients with non-small cell lung cancer]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:31–34

    PubMed  Google Scholar 

  • Liu CG, Calin GA, Volinia S et al (2008a) MicroRNA expression profiling using microarrays. Nat Protoc 3:563–578

    Article  CAS  Google Scholar 

  • Liu CG, Spizzo R, Calin GA et al (2008b) Expression profiling of microRNA using oligo DNA arrays. Methods 44:22–30

    Article  Google Scholar 

  • Lowery AJ, Miller N, McNeill RE et al (2008) MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res 14:360–365

    Article  CAS  PubMed  Google Scholar 

  • Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838

    Article  CAS  PubMed  Google Scholar 

  • McManus MT (2003) MicroRNAs and cancer. Semin Cancer Biol 13:253–258

    Article  CAS  PubMed  Google Scholar 

  • Meng F, Henson R, Lang M et al (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113–2129

    Article  CAS  PubMed  Google Scholar 

  • Michael MZ, O'Connor SM, van Holst Pellekaan NG et al (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1:882–891

    CAS  PubMed  Google Scholar 

  • Moore MJ, Goldstein D, Hamm J et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25:1960–1966

    Article  CAS  PubMed  Google Scholar 

  • Nelson PT, Baldwin DA, Scearce LM et al (2004) Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods 1:155–161

    Article  CAS  PubMed  Google Scholar 

  • Paez JG, Janne PA, Lee JC et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497–1500

    Article  CAS  PubMed  Google Scholar 

  • Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226–230

    Article  CAS  PubMed  Google Scholar 

  • Reinhart BJ, Slack FJ, Basson M et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901–906

    Article  CAS  PubMed  Google Scholar 

  • Schmittgen TD, Lee EJ, Jiang J et al (2008) Real-time PCR quantification of precursor and mature microRNA. Methods 44:31–38

    Article  CAS  PubMed  Google Scholar 

  • Schutte M, Hruban RH, Geradts J et al (1997) Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 57:3126–3130

    CAS  PubMed  Google Scholar 

  • Simeone DM, Ji B, Banerjee M et al (2007) CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 34:436–443

    Article  CAS  PubMed  Google Scholar 

  • Soung YH, Lee JW, Kim SY et al (2005) Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch 446:483–488

    Article  CAS  PubMed  Google Scholar 

  • Takamizawa J, Konishi H, Yanagisawa K et al (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753–3756

    Article  CAS  PubMed  Google Scholar 

  • Tang F, Hajkova P, Barton SC et al (2006) 220-plex microRNA expression profile of a single cell. Nat Protoc 1:1154–1159

    Article  CAS  PubMed  Google Scholar 

  • Yekta S, Shih IH, Bartel DP (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science 304:594–596

    Article  CAS  PubMed  Google Scholar 

  • Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214–220

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. TGen Clinical Research Services, Translational Genomics Research Institute (TGen), 445 N. Fifth Street, Phoenix, AZ, 85004, USA

    Glen J. Weiss

Authors
  1. Aarati R. Ranade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Glen J. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Glen J. Weiss .

Editor information

Editors and Affiliations

  1. Institute, Translational Genomics Research, 445 N. Fifth Street, Phoenix, 85004, U.S.A.

    Haiyong Han

  2. Feinberg School of Medicine, Northwestern University, Chicago, 60611, U.S.A.

    Paul Grippo

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ranade, A., Weiss, G. (2010). MicroRNA Profiling and Its Application in Drug Discovery in Pancreatic Cancer. In: Han, H., Grippo, P. (eds) Drug Discovery in Pancreatic Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1160-5_9

Download citation

Publish with us

Policies and ethics

Search

Navigation